A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy ...

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

During the dog days of summer, columnist Sam Kirton takes special care to protect himself from medication side effects.

That’s according to top-line data from the Phase 2b CORAL trial (NCT05964335), which is evaluating three doses of the experimental oral therapy against a placebo, taken twice a day, in 165 adults.

FIBRONEER-IPF (NCT05321069) enrolled 1,177 IPF patients, while FIBRONEER-ILD (NCT05321082) enrolled 1,176 adults with progressive forms of pulmonary fibrosis other than IPF. Because the studies met ...

Let-7, an established tumor suppressor microRNA that controls gene activity, plays a key role in lung tissue repair and the development of pulmonary fibrosis (PF), which is marked by scarring of the ...

Welcome, LGBTQIA+ organ donors. When I received my bilateral lung transplant in July 2021, I wasn’t told anything about my donor. Even today, I have no information about this person. I can tell you ...